129 related articles for article (PubMed ID: 1580643)
21. [A phase I study of DWA2114R].
Ariyoshi Y; Wakui A; Hasegawa K; Niitani H; Ogawa M; Sakai Y; Majima H; Furue H; Miyake H; Taguchi T
Gan To Kagaku Ryoho; 1992 May; 19(5):685-93. PubMed ID: 1580642
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of gynecological cancer with cis-platinum].
Mano T; Takeshima N; Nakamura Y; Tomimatsu T; Saito T; Miyake T
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2895-9. PubMed ID: 3662545
[TBL] [Abstract][Full Text] [Related]
23. Activity of JM9 in advanced ovarian cancer: a phase I-II trial.
Bramwell VH; Crowther D; O'Malley S; Swindell R; Johnson R; Cooper EH; Thatcher N; Howell A
Cancer Treat Rep; 1985 Apr; 69(4):409-16. PubMed ID: 3995511
[TBL] [Abstract][Full Text] [Related]
24. [Phase II study of carboplatin in cervical carcinoma].
Noda K; Kato T; Ikeda M; Akiya K; Yajima A; Ueda G; Nishiya I; Takamizawa H; Terashima Y; Tsutsui F
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3067-72. PubMed ID: 3056277
[TBL] [Abstract][Full Text] [Related]
25. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
Kamiura S; Kobayashi K; Ohira H; Seino H; Hashimoto N; Sawai K; Samejima Y; Saji F
Gan To Kagaku Ryoho; 2001 Jul; 28(7):979-86. PubMed ID: 11478148
[TBL] [Abstract][Full Text] [Related]
26. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
Plaxe SC; Blessing JA; Bookman MA; Creasman WT
Gynecol Oncol; 2002 Jan; 84(1):32-5. PubMed ID: 11748972
[TBL] [Abstract][Full Text] [Related]
28. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
[TBL] [Abstract][Full Text] [Related]
29. Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
Chambers SK; Davis CA; Schwartz PE; Kohorn EI; Chambers JT
Clin Cancer Res; 1996 Oct; 2(10):1693-7. PubMed ID: 9816118
[TBL] [Abstract][Full Text] [Related]
30. [Phase II study of carboplatin in ovarian cancer].
Kato T; Nishimura H; Yamabe T; Terashima Y; Kasamatsu T; Hirabayashi K; Nishiya I; Yajima A; Takamizawa H; Tsutsui F
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2291-6. PubMed ID: 3044275
[TBL] [Abstract][Full Text] [Related]
31. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
32. [Phase II study of cisplatin in cervical and endometrial carcinomas].
Noda K; Takeuchi S; Kurihara S; Sugawa T; Kato T; Ikeda M; Kanazawa K; Tsutsui F; Yamamoto K; Umezu J
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1129-35. PubMed ID: 3566307
[TBL] [Abstract][Full Text] [Related]
33. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of carboplatin in non-small cell lung cancer.
Tamura T; Shinkai T; Eguchi K; Sasaki Y; Fujiwara Y; Fukuda M; Ohe Y; Nakagawa K; Minato K; Saijo N
Jpn J Clin Oncol; 1989 Mar; 19(1):51-5. PubMed ID: 2537907
[TBL] [Abstract][Full Text] [Related]
35. Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group study.
Markman M; Blessing JA; Alvarez RD; Hanjani P; Waggoner S; Hall K
Gynecol Oncol; 2000 Apr; 77(1):112-5. PubMed ID: 10739699
[TBL] [Abstract][Full Text] [Related]
36. [A phase II study of carboplatin to bronchogenic carcinoma of the lung. Carboplatin Cooperative Study Group for Lung Carcinoma].
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2139-44. PubMed ID: 2840036
[TBL] [Abstract][Full Text] [Related]
37. A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP).
Mathé G; Kidani Y; Triana K; Brienza S; Ribaud P; Goldschmidt E; Ecstein E; Despax R; Musset M; Misset JL
Biomed Pharmacother; 1986; 40(10):372-6. PubMed ID: 3580505
[TBL] [Abstract][Full Text] [Related]
38. A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma.
Rose PG; Gordon NH; Fusco N; Fluellen L; Rodriguez M; Ingalls ST; Hoppel CL
Gynecol Oncol; 2000 Aug; 78(2):228-34. PubMed ID: 10926808
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].
Hirabayashi K; Okada E; Oguma T; Shimamura K
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2221-7. PubMed ID: 2241186
[TBL] [Abstract][Full Text] [Related]
40. [Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
Zhu WG; Yu CH; Li T
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):525-6. PubMed ID: 22093631
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
